Friday, June 23, 2017

Insider Tips to Help Meet Patient Management Standards in URAC’s Specialty Pharmacy v3.0 Accreditation

Today’s guest post comes from Russel Allinson, co-founder, Chief Executive Officer, and Chief Clinical Officer of Therigy.

Russ discusses the importance of understanding the latest URAC Specialty Pharmacy v3.0 accreditation requirements, particularly relating to patient management. To learn more, register for a free webinar co-hosted by Therigy and Cleveland Clinic. The webinar will be held on July 11, 2017, at 1:00 p.m. EDT.

Read on for Russ's insights.

Insider Tips to Help Meet Patient Management Standards in URAC’s Specialty Pharmacy v3.0 Accreditation
By Russel Allinson, co-founder, Chief Executive Officer, and Chief Clinical Officer of Therigy

Accreditation has become an important step for specialty pharmacies to stay competitive and earn contracts with big pharma and payers. The accreditation process itself helps specialty pharmacies improve their processes to meet the demands of today’s value-based reimbursement environment. But accreditation is not an easy process to go through. Preparing in advance can help specialty pharmacies avoid potential major hurdles.

Considerable changes were made to the patient management standards when URAC released Specialty Pharmacy v3.0 Accreditation in 2015. All specialty pharmacies applying for accreditation should understand these changes, including those preparing for reaccreditation.

To help specialty pharmacies understand the patient management standards changes, and to provide tips to prepare, Therigy and Cleveland Clinic will co-host an educational webinar on Tuesday, July 11, 2017 at 1:00 p.m. EDT.

THE NEW CHALLENGES OF 3.0

While some areas of URAC Specialty Pharmacy v3.0 requirements remain untouched since the last version, a number of areas have seen significant changes. (See URAC's Standards & Measures at a Glance) This is particularly true for the patient management standards, where several standards have been edited, added, and deleted, in addition to undergoing name, number, and weighting changes.

The documentation standards may be especially cumbersome for some pharmacies. Specialty pharmacies are required to document comprehensive patient management overviews in their policies and procedures, including details about adherence evaluation and the effectiveness of therapies and drugs. Overviews for patients who take specialty drugs need to include assessments, reassessments, education, and opt-outs—all of which need to be reviewed by a clinician, even if performed by non-clinical staff.

USING TECHNOLOGY TO FILL THE GAPS

With such strict requirements for management and documentation, it’s non-negotiable for pharmacies to have a consistent and reliable system in place. While URAC does accept its rigorous requirements in the form of paper trails from manual and legacy systems, more specialty pharmacies are turning to advanced technology partners to help digitize and systematize their operations and make sure nothing falls between the cracks.

The right platform can integrate with existing systems, offering key help in areas like patient management, patient safety, specialty drug management, and drug utilization management. In addition to simply making specialty pharmacies more efficient and more prepared on the operational side, they also offer customizable tools to meet each pharmacy’s reporting needs.

WHAT TO EXPECT FROM THE WEBINAR

My colleague Pam DeVaul, Vice President of Quality at Therigy, and Chase Dye, Operations Manager of Cleveland Clinic, will join me for this webinar presentation to share our insider knowledge.

We will discuss special considerations for earning URAC Specialty Pharmacy v3.0 accreditation, the key differences related to patient management, and how to plan and execute needed changes into specialty drug management programs. We will also offer tips that specialty pharmacies can apply to their accreditation processes.

By the end of the webinar, attendees will understand how to:
  1. Navigate the major changes in URAC Specialty Pharmacy v3.0 for patient management
  2. Apply the URAC Specialty Pharmacy v3.0 standards for patient management to specialty pharmacy accreditation
  3. Plan and implement URAC Specialty Pharmacy v3.0 requirements for patient management
  4. Use technology to meet the new patient- and specialty-drug management standards
If you’re interested in learning about important considerations and strategies to help prepare for the URAC Specialty Pharmacy v3.0 accreditation or reaccreditation process, visit www.therigy.com/uracwebinar to register for the free webinar on Tuesday, July 11, 2017 at 1:00 p.m. EDT.

ABOUT THERIGY

Therigy® is a patient-focused specialty therapy management company that offers leading consulting and technology solutions, including the TherigySTM™ platform. Therigy equips pharmacy stakeholders with the tools to scale and standardize patient management programs, helping them to deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends.

ABOUT CLEVELAND CLINIC

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion, and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.


Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. These posts do not necessarily reflect our opinions and should not be considered endorsements.

To find out how you can publish a guest post on Drug Channels, please contact Paula Fein (paula@drugchannelsinstitute.com).

No comments:

Post a Comment